Colgate-Palmolive (NYSE:CL) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 11.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 147,469 shares of the company’s stock after selling 18,870 shares during the period. State of Alaska Department of Revenue’s holdings in Colgate-Palmolive were worth $13,279,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Union Savings Bank increased its position in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares during the last quarter. Avion Wealth increased its position in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $32,000. Core Wealth Advisors Inc. increased its position in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after purchasing an additional 146 shares during the last quarter. Finally, McGlone Suttner Wealth Management Inc. acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $34,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.2 %

Shares of NYSE:CL opened at $95.89 on Thursday. The stock has a market capitalization of $78.67 billion, a price-to-earnings ratio of 30.35, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $99.08. The company’s fifty day moving average is $94.17 and its two-hundred day moving average is $87.90. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.73 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be issued a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.09%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Analysts Set New Price Targets

Several equities analysts recently commented on CL shares. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 28th. Barclays boosted their price objective on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 30th. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Finally, Royal Bank of Canada boosted their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Monday, April 29th. Three equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $93.83.

Insider Buying and Selling

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.